IIR "8th Annual Generic Drugs Summit" Conference, Washington D.C., Sept. 17-19

The Institute for International Research will be holding its 8th annual "Generic Drugs Summit" at the Fairmont Hotel in Washington, D.C., September 17-19.  According to IIR, this is "the leading independent forum for addressing business and legal concerns impacting the Generics marketplace."

The conference features three pre-event symposia and workshops on September 17:

• Full day: Generic Biologics: Understanding the Scientific, Legal, Regulatory, Economic and Marketing Implications
• Morning: Strategies for Filing Successful Paragraph IV Certifications
• Afternoon: Understanding How to Submit Quality ANDAs Based on ObR to Reduce Approval Time

The agenda highlights for the main program, September 18-19, are impressive:

• Q&A with Congressman Henry A. Waxman on Hatch-Waxman reform
• Update and Q&A with Senator Debbie Stabenow on hurdles that slow generics from coming to market
• Update on legislative developments
• Current antitrust actions affecting the generics industry
• An executive roundtable
• A view from Wall Street
• A debate on authorized generics

Additionally, each afternoon will split into two separate tracks: one covering intellectual property and legal issues, the other covering business trends and strategy.

For further information and to register, please visit the conference website.

Orange Book Blog is a media partner of this conference.